The main objective is to advance technology beyond state-of-the-art to:

  • Increase the yield and quality of the products arising from early process streams by optimizing the isolation and fractionation steps performed on the raw materials
  • Modify selected fractionated biomolecules to high value products. The expected achievements will have great impact on the fulfilment of the ambitions of ERA-MarineBiotech.